MedPath

Developing personalized cancer therapy strategy through genomic analysis in liquid biopsy and cancer tissue from metastatic gastrointestinal cancer patients

Not Applicable
Recruiting
Conditions
Neoplasms
Registration Number
KCT0003511
Lead Sponsor
Pusan National University Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
210
Inclusion Criteria

patients with gastrointestinal cancer who have metastasis and who have no other treatment besides chemotherapy are enrolled in this study.

Control group: 1) Among patients diagnosed with gastrointestinal cancer histologically, patients without metastasis
             2) patients with gastrointestinal diseases without cancer

Exclusion Criteria

ECOG 3-4
Patients who refused chemotherapy
Under 18 age
A patient with intellectual disability

Control group: ECOG 3-4, Under 18 age, A patient with intellectual disability

Study & Design

Study Type
Observational Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Tissue mutation status and type, mutation and type in blood Next Generation Sequencing test
Secondary Outcome Measures
NameTimeMethod
survival days
© Copyright 2025. All Rights Reserved by MedPath